Chromatin Bioscience and Purespring Therapeutics Partner to Develop Cell-Selective Synthetic Promoters for Next-Generation Gene Therapies

Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a precision nephrology company leading the de...

October 28, 2025 | Tuesday | News
Fibronostics Acquires Stone Clinical Laboratories to Expand U.S. Operations and Advance Non-Invasive Diagnostics for Metabolic and Liver Diseases

Acquisition expands U.S. lab operations and accelerates innovation in non-invasive diagnostics for metabolic and liver diseases. Fibronostics, a global ...

October 28, 2025 | Tuesday | News
Thermo Fisher Scientific Showcases Next-Generation Biopharma Solutions and AI-Driven Innovations at CPHI Frankfurt 2025

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo ...

October 28, 2025 | Tuesday | News
Vas Narasimhan Calls USD 12 Billion Avidity Acquisition a Defining Move to Advance Novartis Mission in Neuromuscular Disease Treatment

Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases Advances the No...

October 27, 2025 | Monday | News
Xencor Reports Promising Phase 1 Results for XmAb819 in Advanced Clear Cell Renal Cell Carcinoma

-- XmAb819 is well-tolerated in heavily pretreated patients with advanced ccRCC -- -- 25% overall response rate (ORR) observed within the target dose ...

October 27, 2025 | Monday | News
Cytiva Appoints Valérie Marjollet as President of Resins, Filtration, and Cell Culture Media

Cytiva, a global leader in life sciences and bioprocessing technologies under the Danaher Corporation umbrella, has announced the appointment of Val&eacu...

October 24, 2025 | Friday | News
Naobios and Tokyo Metropolitan Institute of Medical Science Partner to Develop Next-Generation Mpox Vaccine

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-ba...

October 24, 2025 | Friday | News
Abzena Grants Orion Exclusive License to CHAb™-Designed Antibody Targeting High-Unmet-Need Cancer

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial...

October 24, 2025 | Friday | News
Ipsen to Acquire ImCheck Therapeutics to Advance Promising AML Immunotherapy ICT01

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high t...

October 23, 2025 | Thursday | News
Elevara Medicines Secures $70M Series A to Advance First-in-Class RA Therapy ELV001

Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001, in-licensed ...

October 23, 2025 | Thursday | News
Marc N. Casper Highlights Thermo Fisher’s 10% Adjusted EPS Growth and Strategic AI Collaboration with OpenAI in Strong Q3 2025 Results

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported its financial results for the third quarter ended September 27, ...

October 23, 2025 | Thursday | Company results
ProImmune Expands UK Operations with New Global Headquarters at Oxford’s Oasis Park

Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UK Increased operationa...

October 23, 2025 | Thursday | News
IDT and Profluent Bio Forge AI-Powered Partnership to Redefine Enzyme Design

Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Profluent Bio, a leader in AI-first protein design, have activate...

October 22, 2025 | Wednesday | News
Agarose Bead Technologies Marks 25 Years with $10 Million Expansion and Global Growth Strategy

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins has announced plans for further expansion, reinforcing its positio...

October 22, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close